Plante Moran Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Plante Moran Financial Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50	Closed	-$4K	–	888
2020 Q3	$4K	Buy	+50	New	+$5.06K	﹤0.01%	708
2019 Q4	–	Sell	-26	Closed	-$2K	–	758
2019 Q3	$2K	Hold	26	–	–	﹤0.01%	764
2019 Q2	$2K	Buy	26 +3	+13%	+$257	﹤0.01%	718
2019 Q1	$2K	Sell	23 -15	-39%	-$1.39K	﹤0.01%	707
2018 Q4	$3K	Buy	38 +21	+124%	+$2K	﹤0.01%	645
2018 Q3	$2K	Sell	17 -8	-32%	-$799	﹤0.01%	679
2018 Q2	$2K	Sell	25 -43	-63%	-$3.77K	﹤0.01%	711
2018 Q1	$6K	Hold	68	–	–	﹤0.01%	684
2017 Q4	$6K	Sell	68 -42	-38%	-$3.65K	﹤0.01%	668
2017 Q3	$10K	Hold	110	–	–	0.01%	537
2017 Q2	$10K	Hold	110	–	–	0.01%	550
2017 Q1	$10K	Buy	+110	New	+$9.79K	0.01%	571
2015 Q4	–	Sell	-12	Closed	-$1K	–	953
2015 Q3	$1K	Buy	+12	New	+$1.6K	﹤0.01%	677
2014 Q3	–	Sell	-15	Closed	-$1K	–	792
2014 Q2	$1K	Hold	15	–	–	﹤0.01%	787
2014 Q1	$1K	Hold	15	–	–	﹤0.01%	576
2013 Q4	$1K	Hold	15	–	–	﹤0.01%	651
2013 Q3	$1K	Buy	+15	New	+$997	﹤0.01%	587

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Plante Moran Financial Advisors's BMRN Position: Q4 2020 in Review

Plante Moran Financial Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2020, closing a stake of 50 shares — an estimated $4K sold.

Plante Moran Financial Advisors first reported a position in BMRN in Q3 2013 and held it in 17 quarters. The position peaked at $10K in Q3 2017. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2020.

Plante Moran Financial Advisors reported no remaining BioMarin Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Plante Moran Financial Advisors sold 50 BioMarin Pharmaceuticals shares in Q4 2020, an estimated $4K.
Plante Moran Financial Advisors first reported a position in BioMarin Pharmaceuticals in Q3 2013 and held it in 17 quarters.
Plante Moran Financial Advisors's BioMarin Pharmaceuticals position peaked at $10K in Q3 2017.
539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.